Cardiac enzyme rises post CABG predict worse outcomes

The significance of myocardial enzyme elevations following coronary artery bypass surgery (CABG) remains controversial.  Although a ‘significant’ enzyme rise is felt to indicate a worse long-term prognosis, several smaller studies have suggested that even small enzyme rises within 24hours of surgery are significant.  This analysis aimed to define whether a threshold exists below which enzyme […]

Read More…

HDL function and atherosclerosis

There is a strong inverse relationship between serum levels of HDL and the risk of developing atherosclerotic cardiovascular disease.  This has fostered the search for pharmacological agents that raise HDL, but while several therapies have shown biochemical benefit – including nicotinic acid, fibrates and CETP inhibitors – there are little convincing data to associate these […]

Read More…

IVUS reveals importance of non-culprit lesions

A substantial proportion of individuals who present with an acute coronary syndrome will go on to have repeat events, however the lesion related factors driving these repeat events remain poorly understood.  Data from retrospective and pathological studies have suggested that many lesions that lead to clinical events are thin-walled lipid-rich lesions that are angiographically mild […]

Read More…

Statins show benefit regardless of CRP

Some previous studies – most noticeably the JUPITER trial – have suggested that the vascular benefits of statin therapy may be greater in the presence of inflammation.  C-reactive protein (CRP), a systemic marker of inflammation, has been associated with the risk of ischaemic heart disease, stroke, and vascular mortality, but its ability to act as […]

Read More…

Candesartan shows superiority in heart failure

In patients with reduced left ventricular ejection fraction (LVEF), angiotensin II receptor blockers (ARBs) have been shown to decrease cardiovascular mortality and hospital admissions for heart failure.  However, despite having different affinities for the AT1 receptor and different effects on outcomes, few ARBs have been compared head-to-head. This study aimed to compare the effects of […]

Read More…